@FierceBiotech: KIT team points pancreatic cancer therapy toward clinical trials. FierceBiotechResearch article | Follow @FierceBiotech
@JohnCFierce: Ex-Lumena gang pilots new course at Amplyx with antifungal R&D, $40.5M. Report | Follow @JohnCFierce
@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." Release | Follow @DamianFierce
> Alnylam Pharmaceuticals ($ALNY) and partner the Medicines Company ($MDCO) said their in-development RNAi treatment charted a sustained reduction of bad cholesterol in an ongoing Phase I trial. Like recently approved medicines from Sanofi ($SNY) and Amgen ($AMGN), the medicine targets PCSK9 to slash LDL cholesterol but is designed to be dosed much less frequently. More
> Hans Schikan, the former CEO of Prosensa, has been named chairman of Switzerland's Asceneuron. Release
> Zurich-based Kuros Biosurgery AG has added CHF 5 million to its latest fundraising, bringing the total to CHF 20 million. Release
> As Sanofi struggles to keep its diabetes business competitive, rival Novo Nordisk ($NVO) is snatching up more market share. Story
Medical Device News
@FierceMedDev: Medtronic reports strong leadless pacemaker data as it races St. Jude to FDA approval. More | Follow @FierceMedDev
@VarunSaxena2: IYCMI from FierceDrugDelivery: Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey. Article | Follow @VarunSaxena2
@EmilyWFierce: Theranos and Safeway split after $350M deal, code-named "T-Rex," falls through. More from the WSJ | Follow @EmilyWFierce
> AliveCor adds former Google exec as CEO to further consumer ECG push. Articles
> Stanford engineers develop touch-free ultrasound device for tumor detection. More
Pharma News
@FiercePharma: GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. Story | Follow @FiercePharma
@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce
@CarlyHFierce: $GSK shoots for diabetes-esque platform approach with new respiratory med in hand. Article | Follow @CarlyHFierce
> Bondholders bail on Valeant amid cash flow concerns. More
> Sources: Novartis faces yet another sanction in Japan. Article
Biotech Research News
> MD Anderson group tracks 'modest' impact of lymphoma drug. Item
> Warp Drive Bio constructs a new cancer R&D tech platform. Story
> Microbiome study highlights bacterial strategy for treating severe diarrhea. News
> Case Western researchers spotlight role of rapid protein movement in hearing loss. More
> KIT team points pancreatic cancer therapy toward clinical trials. Article
Vaccines News
> GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. News
> MenAfriVac succeeds in sub-Saharan Africa, but the fight isn't over yet. More
> James Cook University researcher wins $2M Gates grant for malaria vaccine development. Story
> Novavax kicks off PhIII trial for its RSV vaccine. Article
> EMA safety review raises no issues with HPV vaccines from Merck, GSK. Report
Pharma Marketing News
> $1-per-pill alternative to Turing drug gets 'overwhelming' response: Imprimis CEO. Article
> Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat. Report
> GSK shoots for diabetes-esque platform approach with new respiratory med in hand. More
> Allergan counting on January formulary boost to jump-start Namzaric launch. Story
> AstraZeneca holds on to purple Nexium trademark with early court win. Article